Interventional Psychiatry Division

Where advanced interventions meet relational psychiatry

Play

Some mental health conditions resist standard treatment. For these patients, interventional psychiatry provides safe, evidence-based options that can open new doors to healing. At Krasner Institute, these treatments are never delivered in isolation. They are integrated within the Krasner Faculty Practice Plan, anchored in relational trust, and designed to support transformation through collaboration.

Our interventional services currently include:

Transcranial Magnetic Stimulation (TMS) Ketamine-Assisted Psychotherapy (KAP)

Both are delivered within the Assess. Treat. Plan. framework, ensuring every intervention is personalized, measured, and relationally grounded.

Our Distinctive Approach

1
Integration with Therapists
  • We collaborate closely with a patient’s existing therapist.
  • Treatment is woven into ongoing psychotherapy, never siloed.
  • Insights from interventions flow back into the therapeutic relationship, ensuring continuity.
2
The Faculty Practice Model
  • Every case is reviewed in ensemble-style rounds.
  • Patients benefit from the collective wisdom of psychiatrists, therapists, and interventional specialists.
  • Reliable, accountable systems prevent fragmentation of care.
3
Relational Trust as Central
  • Cutting-edge interventions work best inside a safe, trusting relationship.
  • Trust in the clinical team creates the container for transformation.
  • Our commitment is to transparency, reliability, and respect at every stage.

Our Services

Transcranial Magnetic Stimulation (TMS)

What it is: Non-invasive brain stimulation using magnetic fields to treat depression, OCD, PTSD, and more.

Our difference:

  • Delivered by high-level clinicians (not technicians alone).
  • Integrated into psychotherapy, not treated as a stand-alone “device service.”
  • Available in both standard and accelerated protocols.
Learn More About TMS

Ketamine-Assisted Psychotherapy (KAP)

What it is: A medication-assisted psychotherapy using ketamine to enhance neuroplasticity and therapeutic breakthroughs.

Our difference:

  • Current offering: sublingual ketamine, with planned expansion to IV therapy.
  • Collaborative care with external therapists is central.
  • Emphasis on preparation and post-treatment integration.
  • Relational trust is treated as the essential ingredient for meaningful change.
Learn More About KAP

Why Choose Our Interventional Psychiatry Division?

  • You are never just a procedure.
  • You are supported by an ensemble of clinicians working in concert.
  • You can trust that advanced interventions will be delivered with the same care, rigor, and humanity that define all of our work.

Tier 1: The Core Faculty

Academic: Founders
Musical: Principal Players
Identity: The nucleus of the practice. They are founders, the principal players in the orchestra. They tune the model, play first chair in rounds, and help compose the ATP “score” as it develops.

Benefits: More favorable financial splits, leadership/ambassadorship, and recognition as co-builders of the Krasner Faculty Practice.

Tier 2: The Collegium

Academic: Clinical Associates
Musical: Ensemble
Identity: Trusted colleagues who often join the ensemble but aren’t always in the pit. They’ve performed alongside you and come in for case-specific collaborations.

Benefits: Recognition as reliable collaborators, invitations to select case conferences, and cross-referrals.

Tier 3: The Network

Academic: Affiliate Faculty
Musical: Orchestra Circle
Identity: A wider orbit of clinicians—sometimes geographically distant—trusted for referrals and occasional specialty collaboration. They’re part of the orchestra’s circle, contributing harmonics that enrich the whole but without the fiduciary tether.

Benefits: Belonging to the extended ATP ecosystem, occasional collaboration, and visibility under the broader Krasner Faculty Practice umbrella.

Summary Picture

  • Founders / Principal Players → the nucleus, building the ATP model.
  • Clinical Associates / Ensemble → the near orbit, case-linked collaborators.
  • Affiliate Faculty / Orchestra Circle → the extended constellation, trusted harmonics.

Transcranial Magnetic Stimulation (TMS)

Advanced Brain Stimulation for Treatment-Resistant Conditions

Play

Transcranial Magnetic Stimulation (TMS) is a non-invasive, FDA-approved treatment that uses targeted magnetic fields to stimulate specific areas of the brain associated with mood regulation. Unlike medications that affect the entire body, TMS precisely targets the brain regions involved in depression, OCD, PTSD, and anxiety disorders.

TMS works by delivering focused magnetic pulses to underactive areas of the brain, literally reactivating neural circuits that have become disrupted by mental health conditions. This targeted approach can restore normal brain function and provide significant symptom relief for patients who haven’t responded to traditional treatments.

The Science: How TMS Works Differently

  • Precision Targeting: TMS uses advanced brain mapping to target the exact areas of your brain that need stimulation, particularly the left prefrontal cortex which is often underactive in depression.
  • Non-Invasive and Medication-Free: Unlike psychiatric medications that circulate throughout your body, TMS affects only the targeted brain areas with no systemic side effects. There’s no sedation, memory loss, or need for anesthesia.
  • Neuroplasticity Enhancement: The magnetic stimulation promotes the growth of new neural connections and strengthens existing pathways, creating lasting changes in brain function that persist beyond the treatment period.
  • Research Evidence: Clinical studies demonstrate that approximately 90% of patients with treatment-resistant depression experience significant improvement with TMS therapy, with many achieving complete remission of symptoms.

Our Approach: What Makes TMS at Krasner Institute Different

  • Clinical Integration, Not Just Technology: TMS is delivered by experienced psychiatrists and integrated into your ongoing psychotherapy, not treated as a standalone device service administered by technicians alone.
  • Personalized Treatment Protocols: We offer both standard and accelerated TMS protocols, tailoring the approach to your specific needs, schedule, and treatment response rather than using a one-size-fits-all method.
  • Comprehensive Assessment-Driven Care: TMS treatment is guided by your thorough psychiatric assessment, ensuring the intervention addresses your unique personality, mental function, and family dynamics rather than just targeting symptoms.

What to Expect During Treatment

  • During Treatment: You’ll sit comfortably in a chair while the TMS device delivers gentle magnetic pulses to your scalp. Most patients describe the sensation as light tapping. You remain fully awake and alert throughout the session, and can read, listen to music, or talk with our staff.
  • Session Details: Each treatment takes less than 20 minutes, and you can drive yourself to and from appointments. There’s no recovery time needed—you can return to work or normal activities immediately after each session.
  • Treatment Course: Most patients complete 36 sessions over 6-9 weeks (typically 5 sessions per week initially, then tapering). Some patients benefit from our accelerated protocols which can achieve results more quickly.

Standard and Accelerated TMS

  • Standard Protocol: Traditional TMS delivered over 6-9 weeks with sessions Monday through Friday, allowing gradual but steady improvement in brain function.
  • Accelerated Protocol: Intensive TMS treatment delivered over shorter timeframes for patients who need more rapid relief or have scheduling constraints.
  • Monitoring and Adjustment: We continuously track your progress using validated assessment tools and adjust treatment parameters to optimize your response throughout the course of therapy.

Conditions We Treat with TMS

  • Treatment-resistant depression (failed 2+ antidepressant trials)
  • Major depressive disorder with suicidal ideation
  • Obsessive-compulsive disorder (OCD)
  • Post-traumatic stress disorder (PTSD)
  • Generalized anxiety disorder
  • Panic disorder

TMS is available for patients 15 years and older, with specialized protocols for different age groups and conditions.

Safety and Side Effects

  • Excellent Safety Profile: TMS has been extensively studied and used safely in clinical practice for over two decades. Serious side effects are extremely rare when proper protocols are followed.
  • Common Side Effects: The most frequent side effect is mild scalp discomfort or light headache during or immediately after treatment, which typically resolves after the first few sessions as patients adjust to the sensation.
  • Medical Monitoring: Each patient undergoes comprehensive medical screening before treatment, and we monitor your response and comfort level throughout every session to ensure optimal safety and effectiveness.

Ketamine-Assisted Psychotherapy (KAP)

A transformative intervention, when safely held in relationship.

What is KAP?

Ketamine-Assisted Psychotherapy (KAP) is an innovative treatment for depression, trauma, and other conditions that have not responded to conventional approaches. Unlike traditional antidepressants, ketamine works rapidly by enhancing neuroplasticity—the brain’s capacity to reorganize itself and form new connections.

But the medicine alone is not the therapy. Transformation happens when ketamine is paired with skilled therapeutic guidance and structured integration.

1

Integration with External Therapists

  • We collaborate intentionally with each patient’s existing therapist.
  • Preparation, dosing, and integration sessions are designed with therapist input, ensuring the treatment fits seamlessly into the patient’s ongoing psychotherapy.
  • This prevents the fragmentation that can occur in “ketamine clinics” and strengthens the continuity of care.
2

The Reliability of the Faculty Practice Plan

  • KAP is embedded in the Krasner Faculty Practice, a structured ensemble of psychiatrists, psychotherapists, and interventional specialists.
  • Treatment plans are reviewed and discussed in faculty rounds, ensuring multiple perspectives shape clinical decisions.
  • Patients benefit from the accountability and reliability of a team-based system rather than relying on a single provider.
3

Relational Trust as the Catalyst

  • We believe relational trust is not peripheral but central to therapeutic transformation.
  • Entering the altered state produced by ketamine requires a safe container—trust in the clinical team provides that container.
  • Relational trust allows patients to engage fully, process safely, and carry forward the insights that emerge.

Current Offering:
Sublingual Ketamine

Administration: Sublingual (under the tongue) tablets, carefully dosed for safety and efficacy.

Advantages:

  • Gentler introduction than IV.
  • At-home and supervised options, depending on the patient’s needs.
  • Predictable safety profile with lower barriers to access.

Monitoring: Each patient undergoes medical screening, vitals monitoring, and ongoing psychiatric oversight.

Future Expansion:
IV Ketamine

Timeline: Planned introduction as the interventional division grows.

Advantages of IV

  • Higher precision and control over dosing.
  • Flexible titration to match clinical needs.
  • Conducted in a dedicated medical setting for optimal safety.

Positioning: IV will be offered only within the same relational, faculty-driven framework that defines our KAP program today.

Treatment Journey

1
Assessment & Preparation
  • Comprehensive psychiatric and medical evaluation.
  • Coordination with patient’s therapist.
  • Intention-setting to align goals.
2
Dosing Sessions
  • Sublingual ketamine administered in a safe, monitored setting.
  • Therapeutic presence to guide, witness, and ensure safety.
3
Integration
  • Immediate debriefing and structured integration therapy.
  • Return to ongoing therapist with collaborative handoff and treatment notes.
  • Long-term planning inside the Assess. Treat. Plan. model.

Safety & Evidence

  • Screening: Medical and psychiatric review to rule out contraindications.
  • Monitoring: Vital signs tracked; adverse events are rare and managed with established protocols.
  • Research: Clinical trials consistently show ketamine’s rapid antidepressant effects, particularly in treatment-resistant depression.
  • Our Difference: We pair the evidence base with relational depth, so outcomes are not just symptom relief but meaningful change.

Who May Benefit

  • Treatment-resistant depression
  • Post-traumatic stress disorder (PTSD)
  • Certain anxiety disorders
  • Complicated grief and existential distress
  • Patients who have not found relief through conventional psychotherapy and medication

Patient Experience

1
Before treatment: Guided preparation and intention-setting.
2
During treatment: Safe, supported exploration with therapeutic presence.
3
After treatment: Integration sessions to weave insights into ongoing life and relationships.
4
Throughout: Relational trust and faculty oversight provide a dependable holding environment.

Why Choose KAP
at Krasner Institute

  • We are not a ketamine shop.
  • We are a faculty practice, built on trust, collaboration, and accountability.
  • Every patient is supported by a team of clinicians working in concert.
  • Our model ensures that ketamine is not just an intervention, but a catalyst for enduring transformation.

Ready to Explore Your Options?

You’ve shown incredible courage continuing to seek help. That persistence deserves an approach as dedicated as your efforts have been.

Call: 203-762-6442 Email Us
Schedule Your Assessment Today
Serving Connecticut, New York, and New Jersey with advanced depression treatment options.